Bladder News and Research

RSS

First evidence that personalized medicine leads to better outcomes

A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy.

12 Oct 2009

OncoGenex Pharmaceuticals president named Canada's Pacific Ernst & Young's Entrepreneur Of The Year

OncoGenex Pharmaceuticals, Inc., announced today that Scott Cormack, president and chief executive officer of OncoGenex, has been named Canada's Pacific Ernst & Young's Entrepreneur Of The Year(R). The Ernst & Young Entrepreneur Of The Year(R) Award is a high profile business award recognizing entrepreneurs that are building successful, dynamic businesses.

9 Oct 2009

Urodynamix Technologies commences uroNIRS 2000 pilot program

Urodynamix Technologies Ltd. today announces that it has commenced a pilot sales and marketing program with Cardinal Health for its uroNIRS 2000, an innovative technology for the non-invasive diagnosis of bladder conditions. The 90-day pilot program will be used to by Urodynamix and Cardinal Health to evaluate the viability of adding the uroNIRS 2000 to Cardinal Health's catalogue of offerings to the urology market.

8 Oct 2009

Minimally invasive sling operations for stress urinary incontinence found promising

New, less invasive surgical treatments for stress urinary incontinence in women are just as effective as traditional open surgical approaches, according to Cochrane Researchers. The researchers carried out a systematic review of trials comparing different surgical approaches to treating the condition.

7 Oct 2009

Panel Intelligence expands patient focused market research service

Panel Intelligence, LLC, is pleased to announce expanded capabilities for patient focused market research. For 10 years, Panel Intelligence has provided actionable market intelligence in the form of primary research from clinicians and other healthcare professionals.

7 Oct 2009

New ultrasound probe effective for treating kidney stones

A relatively new ultrasound probe procedure has the highest success rate for breaking down kidney stones in the lower "funnel" area of the kidney, rather than the shock wave treatment used for many years, according to a review of studies.

7 Oct 2009

Uroplasty's Urgent PC and Macroplastique presented at the International Continence Society Meeting

Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.

7 Oct 2009

Signostics launches new palm-sized ultrasound product for diagnosis at the point of care

Signostics Inc., a U.S. and Australian-based medical device company developing innovative portable and affordable handheld medical devices, today announced the launch of its new palm-sized, affordable ultrasound product for point-of-care use by medical practitioners.

5 Oct 2009

Fifth SEEM anniversary meeting to be held in Belgrade

On 9 and 10 October the anniversary South Eastern European Meeting (SEEM) will be held in the Yugoslav Drama Theatre (Jugoslovensko Dramsko Pozoriste) in Belgrade (RS). Professor Michael Marberger (Vienna, AT), chairman of the Regional Office of the European Association of Urology: "For the 5th time the SEEM will provide a platform where new experimental and clinical work from the region is presented to an international audience".

5 Oct 2009

Strengthening the pelvic floor muscles effective for older women with urinary incontinence

Researchers at Rush University Medical Center have found that a program of pelvic floor muscle exercises, combined with pelvic health education, can be an effective way to manage urinary incontinence in elderly women.

3 Oct 2009

61 institutions awarded grants for cancer research from American Cancer Society

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 new national research and training grants totaling $45,097,000 to 61 institutions nationwide in the second of two grants cycles for 2009. The grants go into effect beginning January 1, 2010.

3 Oct 2009

AMS’ products restore patient's pelvic health and their quality of life

American Medical Systems® (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of three major clinical studies that each point to a high degree of efficacy and patient satisfaction with AMS’ minimally invasive treatment options for female stress urinary incontinence (SUI) and vaginal prolapse.

30 Sep 2009

Rite Aid and Atlantic General Hospital sign agreement to open Atlantic ImmediCare clinics

Rite Aid Corporation (NYSE:RAD) and Atlantic General Hospital and Health System today announced an agreement to open Atlantic ImmediCare clinics inside three Rite Aid stores in Ocean Pines and Pocomoke City, Maryland, and Millsboro, Delaware, this fall. The clinics, which will be open daily, will provide extended hours for care in the evening and on weekends.

30 Sep 2009

Quintiles Transnational enter into marketing agreement with Allergan for SANCTURA XR

Quintiles Transnational Corp. and Allergan, Inc. (NYSE: AGN) today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR® (trospium chloride extended release capsules), an anticholinergic approved for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency, predominantly to primary care physicians in the United States.

28 Sep 2009

NHSSC awards contract to AMS to supply SUI treatment devices in UK

American Medical Systems (AMS), a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that it has been included as part of a multiple-awardees contract by National Healthcare Services (NHS) Supply Chain (NHSSC) to supply three of its clinically-proven female stress urinary incontinence (SUI) treatment devices through the Normanton distribution centre, United Kingdom.

24 Sep 2009

Women usually tightlipped about bladder problems

Women may be known as the more talkative sex, but when it comes to a certain sensitive health topic, their lips are sealed, according to a new "Bladder Talk" survey of 780 women aged 35 and older in North America (U.S. and Canada) sponsored by TENA(R), the worldwide leader in the management of bladder protection, and conducted by Harris Interactive.

24 Sep 2009

Bioniche Life Sciences' revenue increases by 21% for the fiscal year 2009

Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2009 fiscal year ended June 30, 2009.

21 Sep 2009

Four single-letter variations in SNPs increse prostate cancer risk

deCODE genetics (Nasdaq: DCGN) today announced that a team of its scientists and academic colleagues from Finland, Spain, the Netherlands and the United States have today published the discovery of four novel single-letter variations in the sequence of the human genome (SNPs) conferring increased risk of prostate cancer.

21 Sep 2009

Bioniche announces fiscal 2009 year-end results

Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2009 fiscal year ended June 30, 2009.

19 Sep 2009

Mayo Clinic Health Letter discusses kidney stone treatment options

Ordinary, loud snoring doesn't seem to be harmful, according to the September issue of Mayo Clinic Health Letter. But snorers still may want to seek treatment to stop snoring, reduce embarrassment and improve sleep for themselves and their bed partner.

17 Sep 2009